The global objective is to support the implementation of the pharmaceutical policy set up by the Ministry of Pharmaceutical Industry, and which aims in particular to improve health safety by strengthening the existing system in order to guarantee quality, the safety and efficacy of pharmaceuticals and medical devices as well as their performance in order to protect public health.
The specific objective to strengthen the capacities of the National Agency of Pharmaceutical Products to ensure its new missions of evaluation, audit, inspection and quality control as well as missions of safety of pharmaceutical products and the performance of medical devices.
Algeria
Bahrain
Egypt
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Libya
Morocco
Oman
Palestine *
Qatar
Saudi Arabia
Syria
Tunisia
United Arab Emirates
Yemen